Oct. 16 Financial Quick Takes: Hong Kong IPO could value Ascentage at $876M; plus Principia, Rhythm, ProQR, dMed, Ionova and Amarna

By Hongjiang Li, Staff Writer and Val Kennedy, Associate Editor | Oct 17, 2019 | 12:28 AM GMT

Editor's note: Updated on Oct 17, 2019 at 12:32 AM GMT

Ascentage sets Hong Kong IPO terms
Ascentage Pharma Group International would raise HK$404.4 million ($51.6 million) and be valued at HK$6.9 billion ($876.4 million) if it prices its Hong Kong IPO at the